Premium
Limitations of the Severe Combined Immunodeficiency (SCID) Mouse Model for Study of Human B‐Cell Responses
Author(s) -
SOMASUNDARAM R.,
JACOB L.,
ADACHI K.,
CLASS R.,
SCHECK S.,
MARUYAMA H.,
HERLYN D.
Publication year - 1995
Publication title -
scandinavian journal of immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.934
H-Index - 88
eISSN - 1365-3083
pISSN - 0300-9475
DOI - 10.1111/j.1365-3083.1995.tb03582.x
Subject(s) - immunology , antibody , immune system , severe combined immunodeficiency , toxoid , in vivo , in vitro , cyclophosphamide , biology , medicine , immunization , chemotherapy , biochemistry , microbiology and biotechnology
Mice lacking functional T and B lymphocytes offer an in vivo animal model for the study of human immune functions. We have attempted to optimize the reconstitution of severe combined immunodeficiency (SCID) mice with human peripheral blood lymphocytes (PBL) using radiation, anti‐asialo GM 1 antibody or cyclophosphamide (Cy) treatment of the mice and in vitro stimulation of human PBL with interleukin (IL)‐2 prior to their transfer to the mice. Total human IgG and tetanus‐toxoid (TT)‐specific human IgG responses of the mice were used as parameters of successful reconstitution. Treatment of the mice with anti‐asialo GM 1 antibody significantly enhanced total human IgG levels, but not TT‐specific antibody responses, whereas irradiation or Cy treatment of the mice had no effect on human antibody production. In vitro treatment of human PBL with IL‐2 prior to engraftment significantly decreased total human IgG responses of human PBL‐grafted SCID mice. The immune responses of individual mice within a group were highly variable, which constitutes a major disadvantage of this model.